Harkof-LS Syrup Sugar Free is a combination medication formulated to provide effective relief from respiratory tract disorders characterized by bronchospasm, excessive mucus production, and cough. Each 5 ml of this syrup contains Levosalbutamol 1 mg, Ambroxol 30 mg, and Guaifenesin 50 mg. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing bronchial smooth muscle, thereby alleviating bronchospasm and improving airflow in conditions such as asthma and chronic obstructive pulmonary disease (COPD). Ambroxol serves as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus, which enhances mucociliary transport and eases expectoration. Guaifenesin functions as an expectorant, increasing the volume and reducing the viscosity of bronchial secretions, promoting productive cough and clearing the airways. The sugar-free formulation makes Harkof-LS Syrup suitable for diabetic patients and those requiring sugar-restricted diets. This combination therapy is indicated for symptomatic management of acute and chronic respiratory conditions involving bronchospasm and mucus hypersecretion. It should be used under medical supervision, with dosage adjustments based on patient age, severity of symptoms, and response to treatment. Common side effects may include mild gastrointestinal discomfort and tremors, warranting consultation with a healthcare provider if adverse reactions occur.